Partnerships —
Built To Win Faster. Driven by Impact

NYB collaborates with global technology leaders to enhance computational capabilities, accelerate algorithm development, and scale infrastructure for biomedical innovation. These alliances enable high-performance data processing, advanced modelling, and secure, enterprise-grade environments for healthcare applications.

Collaboration Scope:

• Data licensing and integration
• Joint algorithm and model development
• GPU and hardware infrastructure collaboration

NYB participates in leading AI accelerator programs to bridge the gap between laboratory-scale botanical research and industrial-grade pharmaceutical development.

Collaboration Scope:

• GPU-accelerated drug-target interaction (DTI) modeling
• Technical mentorship and go-to-market scaling frameworks

NYB works with partners across pharmaceuticals, functional food, dietary supplements, and beauty and personal care to translate discovery into commercially viable solutions. These partnerships focus on accelerating pipelines, validating applications, and unlocking new market opportunities through AI-enabled compound discovery.

Collaboration Scope:

• Contract research (CRO) partnerships
• Joint venture discovery programs
• Platform licensing

NYB partners with universities and research centers to drive molecular innovation, validate discoveries, and bridge the gap between foundational science and real-world applications.

Collaboration Scope:

• Joint laboratories and research programs
• Clinical validation and translational studies
• Molecular and genomic research initiatives

NYB collaborates with distribution and commercial partners to bring AI-discovered nutraceutical and therapeutic solutions to market. These partnerships focus on market access, brand positioning, and scalable commercialization across key regions.

Collaboration Scope:

• Nutraceutical market expansion
• Therapeutic product distribution
• Go-to-market and channel development